Solid-State Investigation of a Novel (1:2) Venlafaxine-Catechol Cocrystal: Structural, Thermal, Spectroscopic, and Solubility Studies
- 1São Paulo State University , , , ,
- 2Federal University of ABC , , , ,
Abstract
This work reports the third cocrystal of venlafaxine (VLF), expanding the limited database of multicomponent solid forms of this clinically important antidepressant. A systematic cocrystal screening is conducted using a mechanochemical method and catechol (CAT) as coformer. The structure of the novel cocrystal is successfully solved from powder X-ray diffraction data, providing detailed insights into its crystal lattice and revealing a venlafaxine-catechol cocrystal in 1:2 stoichiometry. Hirshfeld surface analysis is employed to characterize the distribution and nature of intermolecular interactions within the cocrystal. A binary phase diagram of the system shows the formation of one cocrystal and two eutectic mixtures at different stoichiometric ratios (7:3 and 1:4 (n/n)). All solid forms are further characterized by DSC, PXRD, and FTIR spectroscopy, confirming their distinct structural and chemical features. Solubility studies show that the cocrystal exhibits the highest solubility in comparison to the eutectic mixtures and pure VLF, while the eutectics also enhance solubility relative to the VLF. These results indicate that the enhanced solubilization of the eutectic systems results from the combined effects of CAT-mediated solubilization and solid-state transformations, including in situ formation of the (1:2) VLF-CAT cocrystal, with the extent of these processes depending on the initial solid-state composition. The identification of a novel (1:2) VLF-CAT cocrystal, alongside the characterization of eutectic mixtures, highlights the relevance of cocrystallization strategies for improving the bioavailability, physical stability, and potential therapeutic performance of poorly water-soluble drugs. These findings provide a framework for the rational design of multicomponent solid forms, with implications for future pharmaceutical development and optimization of drug formulations.
Related
- How Molecular Weight Shapes the Relative Importance of Chemical and Structural Descriptors for Aqueous Solubility
- Phytochemical Investigation and Cytotoxic Activity of Annona amazonica (Annonaceae): Comprehensive Spectroscopic Characterization of N-Formylactinodaphnine
- Structural and Spectroscopic Characterization of Self-Sufficient Cytochrome P450 Fusion Enzymes: CYP102A1 and CYP116B
- Structural and Spectroscopic Characterization of Californium Polyoxometalate Compounds
- Integrated Experimental and Computational Investigation of Fluorinated Benzoylthiourea Derivatives: Structural Characterization, Hirshfeld Surface Analysis, Antioxidant Activity, and MAO–B Inhibitory Potential for Parkinson’s Disease
BibTeX
@article{costa2026solidstate,
title = {{Solid-State Investigation of a Novel (1:2) Venlafaxine-Catechol Cocrystal: Structural, Thermal, Spectroscopic, and Solubility Studies}},
author = {Giovanna de Paula Costa and Patrícia Osório Ferreira and Guilherme Isquibola and Juliana Guedes dos Santos and Fabio Furlan Ferreira and Flávio Junior Caires},
journal = {ACS Omega},
year = {2026},
month = oct,
doi = {10.1021/acsomega.6c04465},
url = {https://pubs.acs.org/acsodf/article/11/41/62777/5447134/Solid-State-Investigation-of-a-Novel-1-2},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Solid-State Investigation of a Novel (1:2) Venlafaxine-Catechol Cocrystal: Structural, Thermal, Spectroscopic, and Solubility Studies
AU - Giovanna de Paula Costa
AU - Patrícia Osório Ferreira
AU - Guilherme Isquibola
AU - Juliana Guedes dos Santos
AU - Fabio Furlan Ferreira
AU - Flávio Junior Caires
PY - 2026
DA - 2026/10/08
JO - ACS Omega
DO - 10.1021/acsomega.6c04465
UR - https://pubs.acs.org/acsodf/article/11/41/62777/5447134/Solid-State-Investigation-of-a-Novel-1-2
AB - This work reports the third cocrystal of venlafaxine (VLF), expanding the limited database of multicomponent solid forms of this clinically important antidepressant. A systematic cocrystal screening is conducted using a mechanochemical method and catechol (CAT) as coformer. The structure of the novel cocrystal is successfully solved from powder X-ray diffraction data, providing detailed insights into its crystal lattice and revealing a venlafaxine-catechol cocrystal in 1:2 stoichiometry. Hirshfeld surface analysis is employed to characterize the distribution and nature of intermolecular interactions within the cocrystal. A binary phase diagram of the system shows the formation of one cocrystal and two eutectic mixtures at different stoichiometric ratios (7:3 and 1:4 (n/n)). All solid forms are further characterized by DSC, PXRD, and FTIR spectroscopy, confirming their distinct structural and chemical features. Solubility studies show that the cocrystal exhibits the highest solubility in comparison to the eutectic mixtures and pure VLF, while the eutectics also enhance solubility relative to the VLF. These results indicate that the enhanced solubilization of the eutectic systems results from the combined effects of CAT-mediated solubilization and solid-state transformations, including in situ formation of the (1:2) VLF-CAT cocrystal, with the extent of these processes depending on the initial solid-state composition. The identification of a novel (1:2) VLF-CAT cocrystal, alongside the characterization of eutectic mixtures, highlights the relevance of cocrystallization strategies for improving the bioavailability, physical stability, and potential therapeutic performance of poorly water-soluble drugs. These findings provide a framework for the rational design of multicomponent solid forms, with implications for future pharmaceutical development and optimization of drug formulations.
SN - 2470-1343
ER -